SPP1 expression serves as a potential peripheral circulating biomarker for lung cancer prognostics and drives tumorigenesis
Open Access
- 1 May 2026
- journal article
- Published by KEAI Publishing in Genes & Diseases
- Vol. 13 (3) , 101994
Abstract
No abstract availableFunding Information
- National Natural Science Foundation of China
This publication has 5 references indexed in Scilit:
- SPP1 is required for maintaining mesenchymal cell fate in pancreatic cancerNature, 2025
- Osteopontin in Chronic Inflammatory Diseases: Mechanisms, Biomarker Potential, and Therapeutic StrategiesBiology, 2025
- Osteopontin promotes tumor microenvironment remodeling and therapy resistanceCancer Letters, 2025
- m6A RNA methyltransferase METTL16 induces Cr(VI) carcinogenesis and lung cancer development through glutamine biosynthesis and GLUL expressionJournal of Hazardous Materials, 2024
- RNA methyltransferase NSUN2-mediated m5C methylation promotes Cr(VI)-induced malignant transformation and lung cancer by accelerating metabolism reprogrammingEnvironment International, 2024